Suchbegriffe: PARATHYROID HORMONE - BLOOD , . Treffer: 42
Friedl, C; Reibnegger, G; Kramar, R; Zitt, E; Pilz, S; Mann, JFE; Rosenkranz, AR
Mortality in dialysis patients with cinacalcet use: A large observational registry study.
Eur J Intern Med. 2017; 42(5-6):89-95
Doi: 10.1016/j.ejim.2017.05.002
Web of Science
PubMed
FullText
FullText_MUG
Jäger, MD; Serttas, M; Beneke, J; Müller, JA; Schrem, H; Kaltenborn, A; Ramackers, W; Ringe, BP; Gwiasda, J; Tränkenschuh, W; Klempnauer, J; Scheumann, GFW
Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients.
PLoS One. 2017; 12(10): e0186093-e0186093.
Doi: 10.1371/journal.pone.0186093
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Robinson-Cohen, C; Lutsey, PL; Kleber, ME; Nielson, CM; Mitchell, BD; Bis, JC; Eny, KM; Portas, L; Eriksson, J; Lorentzon, M; Koller, DL; Milaneschi, Y; Teumer, A; Pilz, S; Nethander, M; Selvin, E; Tang, W; Weng, LC; Wong, HS; Lai, D; Peacock, M; Hannemann, A; Völker, U; Homuth, G; Nauk, M; Murgia, F; Pattee, JW; Orwoll, E; Zmuda, JM; Riancho, JA; Wolf, M; Williams, F; Penninx, B; Econs, MJ; Ryan, KA; Ohlsson, C; Paterson, AD; Psaty, BM; Siscovick, DS; Rotter, JI; Pirastu, M; Streeten, E; März, W; Fox, C; Coresh, J; Wallaschofski, H; Pankow, JS; de Boer, IH; Kestenbaum, B
Genetic Variants Associated with Circulating Parathyroid Hormone.
J Am Soc Nephrol. 2017; 28(5):1553-1565
Doi: 10.1681/ASN.2016010069
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Fahrleitner-Pammer, A; Belyavskiy, E; Gruebler, MR; Dimai, HP; Amrein, K; Ablasser, K; Martensen, J; Catena, C; Pieske-Kraigher, E; Colantonio, C; Voelkl, J; Lang, F; Alesutan, I; Meinitzer, A; März, W; Brussee, H; Pieske, B; Pilz, S; Tomaschitz, A
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.
PLoS One. 2017; 12(4):e0173799-e0173799
Doi: 10.1371/journal.pone.0173799
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wetzel, J; Pilz, S; Grübler, MR; Fahrleitner-Pammer, A; Dimai, HP; von Lewinski, D; Kolesnik, E; Perl, S; Trummer, C; Schwetz, V; Meinitzer, A; Belyavskiy, E; Völkl, J; Catena, C; Brandenburg, V; März, W; Pieske, B; Brussee, H; Tomaschitz, A; Verheyen, ND
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
J Clin Hypertens (Greenwich). 2017; 19(11):1173-1180
Doi: 10.1111/jch.13064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tomaschitz, A; Verheyen, N; Meinitzer, A; Pieske, B; Belyavskiy, E; Brussee, H; Haas, J; März, W; Pieske-Kraigher, E; Verheyen, S; Ofner-Ziegenfuss, L; Hartaigh, BÓ; Schwetz, V; Aberer, F; Grübler, M; Lang, F; Alesutan, I; Voelkl, J; Gaksch, M; Horina, JH; Dimai, HP; Rus-Machan, J; Stiegler, C; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
J Hypertens. 2016; 34(7):1347-56
Doi: 10.1097/HJH.0000000000000927
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, N; Fahrleitner-Pammer, A; Pieske, B; Meinitzer, A; Belyavskiy, E; Wetzel, J; Gaksch, M; Grübler, MR; Catena, C; Sechi, LA; Van, Ballegooijen, AJ; Brandenburg, VM; Scharnagl, H; Perl, S; Brussee, H; März, W; Pilz, S; Tomaschitz, A
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
J Hypertens. 2016; 34(9):1778-86
Doi: 10.1097/HJH.0000000000001004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Verheyen, ND; Kienreich, K; Gaksch, M; van, Ballegooijen, AJ; Grübler, MR; Hartaigh, BÓ; Schmid, J; Fahrleitner-Pammer, A; Kraigher-Krainer, E; Colantonio, C; Belyavskiy, E; Treiber, G; Catena, C; Brussee, H; Pieske, B; März, W; Tomaschitz, A; Pilz, S
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.
J Clin Hypertens (Greenwich). 2016; 18(6):543-50
Doi: 10.1111/jch.12710
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zittermann, A; Ernst, JB; Pilz, S; Dreier, J; Kuhn, J; Knabbe, C; Gummert, JF; Morshuis, M; Milting, H
Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device.
PLoS One. 2016; 11(10):e0164459-e0164459
Doi: 10.1371/journal.pone.0164459
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zittermann, A; Morshuis, M; Kuhn, J; Pilz, S; Ernst, JB; Oezpeker, C; Dreier, J; Knabbe, C; Gummert, JF; Milting, H
Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.
Eur J Nutr. 2016; 55(1):305-313
Doi: 10.1007/s00394-015-0847-8
Web of Science
PubMed
FullText
FullText_MUG
Fügl, A; Gruber, R; Agis, H; Lzicar, H; Keibl, C; Schwarze, UY; Dvorak, G
Alveolar bone regeneration in response to local application of calcitriol in vitamin D deficient rats.
J Clin Periodontol. 2015; 42(1):96-103
Doi: 10.1111/jcpe.12342
Web of Science
PubMed
FullText
FullText_MUG
Lerchbaum, E; Schwetz, V; Nauck, M; Völzke, H; Wallaschofski, H; Hannemann, A
Lower bone turnover markers in metabolic syndrome and diabetes: the population-based Study of Health in Pomerania.
Nutr Metab Cardiovasc Dis. 2015; 25(5):458-463
Doi: 10.1016/j.numecd.2015.02.002
Web of Science
PubMed
FullText
FullText_MUG
Pihlstrøm, H; Dahle, DO; Mjøen, G; Pilz, S; März, W; Abedini, S; Holme, I; Fellström, B; Jardine, AG; Holdaas, H
Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
Transplantation. 2015; 99(2):351-359
Doi: 10.1097/TP.0000000000000583
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schneider, A; Schneider, MP; Krieter, DH; Genser, B; Scharnagl, H; Stojakovic, T; Wanner, C; Drechsler, C
Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial.
PLoS One. 2015; 10(5):e0128079-e0128079
Doi: 10.1371/journal.pone.0128079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tomaschitz, A; Verheyen, N; Gaksch, M; Meinitzer, A; Pieske, B; Kraigher-Krainer, E; Colantonio, C; März, W; Schmidt, A; Belyavskiy, E; Rus-Machan, J; van, Ballegooijen, AJ; Stiegler, C; Amrein, K; Ritz, E; Fahrleitner-Pammer, A; Pilz, S
Homoarginine in patients with primary hyperparathyroidism.
Am J Med Sci. 2015; 349(4):306-11
Doi: 10.1097/MAJ.0000000000000419
Web of Science
PubMed
FullText
FullText_MUG
Tomaschitz, A; Pilz, S
Interplay between sodium and calcium regulatory hormones: a clinically relevant research field.
Hypertension. 2014; 63(2): 212-214.
Doi: 10.1161/HYPERTENSIONAHA.113.02253
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
van Ballegooijen, AJ; Reinders, I; Visser, M; Dekker, JM; Nijpels, G; Stehouwer, CD; Pilz, S; Brouwer, IA
Serum Parathyroid Hormone in Relation to All-Cause and Cardiovascular Mortality: The Hoorn Study.
J Clin Endocrinol Metab. 2013; 98(4):E638-E645
Doi: 10.1210/jc.2012-4007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bieglmayer, C; Dimai, HP; Gasser, RW; Kudlacek, S; Obermayer-Pietsch, B; Woloszczuk, W; Zwettler, E; Griesmacher, A
Biomarkers of bone turnover in diagnosis and therapy of osteoporosis : A consensus advice from an Austrian working group.
Wien Med Wochenschr. 2012; 162(21-22):464-477
Doi: 10.1007/s10354-012-0133-9
PubMed
FullText
FullText_MUG
Pilz, S; Kienreich, K; Drechsler, C; Ritz, E; Fahrleitner-Pammer, A; Gaksch, M; Meinitzer, A; März, W; Pieber, TR; Tomaschitz, A
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study.
J Clin Endocrinol Metab. 2012; 97(1):E75-9
Doi: 10.1210/jc.2011-2183
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wagner, D; Amrein, K; Dimai, HP; Kniepeiss, D; Tscheliessnigg, KH; Kornprat, P; Dobnig, H; Pieber, T; Fahrleitner-Pammer, A
Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Transplantation. 2012; 93(3):331-336
Doi: 10.1097/TP.0b013e31823f7f68
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Amrein, K; Schilcher, G; Fahrleitner-Pammer, A
Hypercalcaemia in asymptomatic sarcoidosis unmasked by a vitamin D loading dose.
Eur Respir J. 2011; 37(2): 470-471.
Doi: 10.1183/09031936.00136910
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Grandi, NC; Breitling, LP; Hahmann, H; Wüsten, B; März, W; Rothenbacher, D; Brenner, H
Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease.
Heart. 2011; 97(15):1215-1221
Doi: 10.1136/hrt.2011.223529
Web of Science
PubMed
FullText
FullText_MUG
Zitt, E; Kirsch, AH; Haueis, M; Strasak, A; Neyer, U; Mayer, G; Rosenkranz, AR
The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients.
Clin Nephrol. 2011; 75(4):309-318
Doi: 10.5414/CNP75309
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chandran, M; Hoeck, HC; Wong, HC; Zhang, RF; Dimai, HP
Vitamin d status and its relationship with bone mineral density and parathyroid hormone in southeast asian adults with low bone density.
Endocr Pract. 2010; 17(2): 226-234.
Doi: 10.4158/EP10202.OR
Web of Science
PubMed
FullText
FullText_MUG
Pilz, S; Tomaschitz, A; Drechsler, C; Ritz, E; Boehm, BO; Grammer, TB; März, W
Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.
Eur Heart J. 2010; 31(13): 1591-1598.
Doi: 10.1093/eurheartj/ehq109
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Pilz, S; Tomaschitz, A; März, W; Cavalier, E; Ritz, E
Aldosterone and parathyroid hormone: a complex and clinically relevant relationship.
Calcif Tissue Int. 2010; 87(4): 373-374.
Doi: 10.1007/s00223-010-9409-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Drechsler, C; Krane, V; Grootendorst, DC; Ritz, E; Winkler, K; März, W; Dekker, F; Wanner, C; German Diabetes and Dialysis Study Investigators
The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.
Nephrol Dial Transplant. 2009; 24(10):3151-3157
Doi: 10.1093/ndt/gfp260
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hesse, M; Fröhlich, LF; Zeitz, U; Lanske, B; Erben, RG
Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.
Matrix Biol. 2007; 26(2): 75-84.
Doi: 10.1016/j.matbio.2006.10.003
Web of Science
PubMed
FullText
FullText_MUG
März, W; Seelhorst, U; Wellnitz, B; Tiran, B; Obermayer-Pietsch, B; Renner, W; Boehm, BO; Ritz, E; Hoffmann, MM
Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality.
J Clin Endocrinol Metab. 2007; 92(6):2363-2369
Doi: 10.1210/jc.2006-0071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Dobnig, H; Piswanger-Sölkner, JC; Roth, M; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Sieberer, C; Fahrleitner-Pammer, A
Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk.
J Clin Endocrinol Metab. 2006; 91(9):3355-3363
Doi: 10.1210/jc.2006-0460
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Herberth, J; Fahrleitner-Pammer, A; Obermayer-Pietsch, B; Krisper, P; Holzer, H; Malluche, HH; Dobnig, H
Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
Clin Nephrol. 2006; 65(5):328-334
Doi: 10.5414/CNP65328
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Asmus, HG; Braun, J; Krause, R; Brunkhorst, R; Holzer, H; Schulz, W; Neumayer, HH; Raggi, P; Bommer, J
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density.
Nephrol Dial Transplant. 2005; 20(8):1653-1661
Doi: 10.1093/ndt/gfh894
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kudlacek, S; Schneider, B; Peterlik, M; Leb, G; Klaushofer, K; Weber, K; Woloszczuk, W; Willvonseder, R; Austrian Study Group on Normative Values of Bone Metabolism
Assessment of vitamin D and calcium status in healthy adult Austrians.
Eur J Clin Invest. 2003; 33(4):323-331
Doi: 10.1046/j.1365-2362.2003.01127.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fahrleitner, A; Dobnig, H; Obernosterer, A; Pilger, E; Leb, G; Weber, K; Kudlacek, S; Obermayer-Pietsch, BM
Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.
J Gen Intern Med. 2002; 17(9):663-669
Doi: 10.1046/j.1525-1497.2002.11033.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Floegel, I; Klein, A; Langmann, G
Metastatic sclerochoroidal calcification involving the fovea.
Retina. 2002; 22(4):503-505
Doi: 10.1097/00006982-200208000-00021
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Dimai, HP; Domej, W; Leb, G; Lau, KH
Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia.
J Bone Miner Res. 2001; 16(11):2132-2141
Doi: 10.1359/jbmr.2001.16.11.2132
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dimai, HP; Porta, S; Wirnsberger, G; Lindschinger, M; Pamperl, I; Dobnig, H; Wilders-Truschnig, M; Lau, KH
Daily oral magnesium supplementation suppresses bone turnover in young adult males.
J Clin Endocrinol Metab. 1998; 83(8):2742-2748
Doi: 10.1210/jcem.83.8.5015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Kotzmann, H; Köller, M; Abela, C; Clodi, M; Riedl, M; Graninger, W; Niederle, B; Luger, A
Effects of parathyroid hormone and serum calcium on the phenotype and function of mononuclear cells in patients with primary hyperparathyroidism.
Eur J Clin Invest. 1998; 28(5): 353-358.
Doi: 10.1046/j.1365-2362.1998.00283.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Wildburger, R; Zarkovic, N; Tonkovic, G; Skoric, T; Frech, S; Hartleb, M; Loncaric, I; Zarkovic, K
Post-traumatic hormonal disturbances: prolactin as a link between head injury and enhanced osteogenesis.
J Endocrinol Invest. 1998; 21(2):78-86
Doi: 10.1007/BF03350319
Web of Science
PubMed
FullText
FullText_MUG
Salmhofer, W; Pierer, G; Auer-Grumbach, P; Soyer, HP; Kerl, H
Cutaneous calciphylaxis in chronic renal failure
Hautarzt. 1995; 46(10):726-731
Doi: 10.1007%2Fs001050050330
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Stiegler, C; Leb, G; Kleinert, R; Warnkross, H; Ramschak-Schwarzer, S; Lipp, R; Clarici, G; Krejs, GJ; Dobnig, H
Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
J Bone Miner Res. 1995; 10(5):751-759
Doi: 10.1002/jbmr.5650100512
Web of Science
PubMed
FullText
FullText_MUG
Lind, P; Langsteger, W; Költringer, P; Eber, B; Kammerhuber, F; Smolle-Jüttner, F; Eber, O
Localization of mediastinal parathyroid adenoma by T1-201 scintiscan and SPECT.
Klin Wochenschr. 1990; 68(9):472-475
Doi: 10.1007/BF01648902
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar